![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2021
Bajwah, Sabrina; Colquitt, Jill; Loveman, Emma; Bausewein, Claudia; Almond, Howard; Oluyase, Adejoke; Dzingina, Mendy; Maddocks, Matthew; Higginson, Irene J. und Wells, Athol
(2021):
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis.
In: Erj Open Research, Bd. 7, Nr. 1, 00107-2020
2017
Behr, Jürgen; Crestani, Bruno; Wells, Athol; Kirchgässler, Klaus und Albera, Carlo
(2017):
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply.
In: Lancet Respiratory Medicine, Bd. 5, Nr. 1, E3-E3
Walsh, Simon L. F.; Maher, Toby M.; Kolb, Martin; Poletti, Venerino; Nusser, Richard; Richeldi, Luca; Vancheri, Carlo; Wilsher, Margaret L.; Antoniou, Katerina M.; Behr, Jürgen; Bendstrup, Elisabeth; Brown, Kevin; Calandriello, Lucio; Corte, Tamera J.; Cottin, Vincent; Crestani, Bruno; Flaherty, Kevin; Glaspole, Ian; Grutters, Jan; Inoue, Yoshikazu; Kokosi, Maria; Kondoh, Yasuhiro; Kouranos, Vasileios; Kreuter, Michael; Johannson, Kerri; Judge, Eoin; Ley, Brett; Margaritopoulos, George; Martinez, Fernando J.; Molina-Molina, Maria; Morais, Antonio; Nunes, Hilario; Raghu, Ganesh; Ryerson, Christopher J.; Selman, Moises; Spagnolo, Paolo; Taniguchi, Hiroyuki; Tomassetti, Sara; Valeyre, Dominique; Wijsenbeek, Marlies; Wuyts, Wim; Hansell, David und Wells, Athol
(2017):
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.
In: European Respiratory Journal, Bd. 50, Nr. 2, 1700936
2016
Behr, Jürgen; Bendstrup, Elisabeth; Crestani, Bruno; Günther, Andreas; Olschewski, Horst; Sköld, C. Magnus; Wells, Athol; Wuyts, Wim; Koschel, Dirk; Kreuter, Michael; Wallaert, Benoit; Lin, Chin-Yu; Beck, Jürgen und Albera, Carlo
(2016):
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
In: Lancet Respiratory Medicine, Bd. 4, Nr. 6: S. 445-453
Currow, David C.; Abernethy, Amy P.; Allcroft, Peter; Banzett, Robert B.; Bausewein, Claudia; Booth, Sara; Carrieri-Kohlman, Virginia; Davidson, Patricia; Disler, Rebecca; Donesky, DorAnne; Dudgeon, Deborah; Ekstrom, Magnus; Farquhar, Morag; Higginson, Irene; Janssen, Daisy; Jensen, Dennis; Jolley, Caroline; Krajnik, Malgorzata; Laveneziana, Pierantonio; McDonald, Christine; Maddocks, Matthew; Morelot-Panzini, Capucine; Moxham, John; Mularski, Richard A.; Noble, Simon; O'Donnell, Denis; Parshall, Mark B.; Pattinson, Kyle; Phillips, Jane; Ross, Joy; Schwartzstein, Richard M.; Similowski, Thomas; Simon, Steffen T.; Smith, Tracy; Wells, Athol; Yates, Patsy; Yorke, Janelle und Johnson, Miriam J.
(2016):
The need to research refractory breathlessness.
In: European Respiratory Journal, Bd. 47, Nr. 1: S. 342-343
2014
Loveman, Emma; Copley, Vicky R.; Colquitt, Jill L.; Scott, David A.; Clegg, Andy J.; Jones, Jeremy; O'Reilly, Katherine M. A.; Singh, Sally; Bausewein, Claudia und Wells, Athol
(2014):
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation.
In: BMC Pharmacology & Toxicology
15:63
[PDF, 395kB]